What Researchers Did
Researchers treated a single patient with Parkinson's disease, severe depression, and anxiety using hyperbaric oxygen therapy for 30 days.
What They Found
After 30 days of hyperbaric oxygen treatment, the patient showed improvements in clinical assessment scores for depression and anxiety. These improvements were noted across the Unified Parkinson's Disease Rating Scale I and II, Hamilton Depression Rating Scale, and Hamilton Anxiety Rating Scale.
Canadian Relevance
No direct Canadian connection identified. This study does not cover a Health Canada-recognised indication for hyperbaric oxygen therapy.
Study Limitations
As a single case report, this study's findings cannot be generalized to a wider population of Parkinson's disease patients.